Semaglutide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Semaglutide and local guidelines before prescribing.

GLP-1 receptor agonist

Mechanism

GLP-1 receptor agonist slowing gastric emptying and reducing appetite.

Uses

Type 2 diabetes, obesity, cardiovascular risk reduction.

Dosing

Side effects

Nausea, vomiting, diarrhoea, pancreatitis, gallstones, retinopathy complications.

Interactions

Slows absorption of oral drugs; insulin and sulfonylureas increase hypoglycaemia.

Contraindications and cautions

Pancreatitis history, medullary thyroid cancer history

Monitoring

HbA1c, weight, eyes

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive; antiemetics

Special advice

Titrate slowly; stop in suspected pancreatitis; avoid in pregnancy; monitor retinopathy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book